Zhenkun Ma - Search Results

Year	Number of Results
2002	2
2003	2
2004	4
2005	3
2006	3
2007	4
2009	3
2010	5
2011	5
2012	5
2013	3
2014	5
2015	9
2016	5
2017	3
2018	2
2019	2
2020	7
2021	3
2022	2
2023	3
2024	2

1

Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials.

Li X, Liu Y, Wang M, Gao L, Liu J, Zhang H, Wu M, Chen H, Lou J, Wang J, Chen J, Geng G, Ma Z, Ding Y. Li X, et al. Among authors: ma z. Lancet Infect Dis. 2024 Feb 12:S1473-3099(24)00003-3. doi: 10.1016/S1473-3099(24)00003-3. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38359854

2

The efficacy and safety of intra-articular dual-acting antibacterial agent (TNP-2092) for implant infection-associated MRSA.

Dai T, Ma C, Zhang F, Wang H, Ma Z, Wang H, Wen Y, Chen L. Dai T, et al. Among authors: ma z. J Infect Dis. 2023 Dec 26:jiad588. doi: 10.1093/infdis/jiad588. Online ahead of print. J Infect Dis. 2023. PMID: 38147364

3

PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis.

Xie H, Chen J, Ma Z, Gao Y, Zeng J, Chen Y, Yang Z, Xu S. Xie H, et al. Among authors: ma z. Prostate. 2024 Mar;84(4):317-328. doi: 10.1002/pros.24647. Epub 2023 Dec 25. Prostate. 2024. PMID: 38145367

4

Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS/miR-214-3p/CCL5 pathway.

Yang Z, Chen JQ, Liu TJ, Chen YL, Ma ZK, Fan YZ, Wang ZX, Xu S, Wang K, Wang XY, Li L, Xie HJ. Yang Z, et al. Asian J Androl. 2023 Nov 14;26(2):195-204. doi: 10.4103/aja202351. Online ahead of print. Asian J Androl. 2023. PMID: 37966336 Free PMC article.

5

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.

Guan B, Wu K, Zeng J, Xu S, Mu L, Gao Y, Wang K, Ma Z, Tian J, Shi Q, Guo P, Wang X, He D, Du Y. Guan B, et al. Among authors: ma z. Oncotarget. 2022 Mar 7;13:507. doi: 10.18632/oncotarget.28206. eCollection 2022. Oncotarget. 2022. PMID: 35284038 Free PMC article.

6

Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.

Ma Z, He S, Yuan Y, Zhuang Z, Liu Y, Wang H, Chen J, Xu X, Ding C, Molodtsov V, Lin W, Robertson GT, Weiss WJ, Pulse M, Nguyen P, Duncan L, Doyle T, Ebright RH, Lynch AS. Ma Z, et al. J Med Chem. 2022 Mar 24;65(6):4481-4495. doi: 10.1021/acs.jmedchem.1c02045. Epub 2022 Feb 17. J Med Chem. 2022. PMID: 35175750 Free PMC article.

7

Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility.

Thompson AM, O'Connor PD, Yardley V, Maes L, Launay D, Braillard S, Chatelain E, Wan B, Franzblau SG, Ma Z, Cooper CB, Denny WA. Thompson AM, et al. Among authors: ma z. ACS Med Chem Lett. 2021 Jan 21;12(2):275-281. doi: 10.1021/acsmedchemlett.0c00649. eCollection 2021 Feb 11. ACS Med Chem Lett. 2021. PMID: 33603975 Free PMC article.

8

Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisal.

Thompson AM, O'Connor PD, Marshall AJ, Yardley V, Maes L, Gupta S, Launay D, Braillard S, Chatelain E, Wan B, Franzblau SG, Ma Z, Cooper CB, Denny WA. Thompson AM, et al. Among authors: ma z. Eur J Med Chem. 2021 Jan 1;209:112914. doi: 10.1016/j.ejmech.2020.112914. Epub 2020 Oct 10. Eur J Med Chem. 2021. PMID: 33268145

9

CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer.

Ma Z, Gao Y, Liu W, Zheng L, Jin B, Duan B, Xie H, Guo P, Zeng J, Wang K, Xu S, Wang X, He D, Li L. Ma Z, et al. Dis Markers. 2020 Nov 1;2020:8899924. doi: 10.1155/2020/8899924. eCollection 2020. Dis Markers. 2020. PMID: 33204367 Free PMC article.

10

Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression.

Yang W, Wang K, Ma J, Hui K, Lv W, Ma Z, Huan M, Luo L, Wang X, Li L, Chen Y. Yang W, et al. Among authors: ma z. Arch Med Res. 2021 Feb;52(2):174-181. doi: 10.1016/j.arcmed.2020.10.005. Epub 2020 Oct 13. Arch Med Res. 2021. PMID: 33059953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year